Initial Statement of Beneficial Ownership (3)
May 18 2022 - 4:07PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Villare Susan M. |
2. Date of Event Requiring Statement (MM/DD/YYYY)
5/12/2022
|
3. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [MRMD]
|
(Last)
(First)
(Middle)
C/O MARIMED INC., 10 OCEANA WAY |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Chief Financial Officer / |
(Street)
NORWOOD,, MA 02062
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 350000 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Option to buy common stock | (1) | 5/2/2027 | Common Stock, par value $.001 per share | 400000 | $0.64 | D | |
Explanation of Responses: |
(1) | Granted to the reporting person on May 2, 2022 (the "Grant Date"), this option is exercisable to acquire 100,000 of the underlying shares on the six (6) month anniversary of the Grant Date (the "Initial Vesting Date") and for an additional 100,000 shares on the last day of every succeeding six (6) month period after the Initial Vesting Date until the option is fully vested. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Villare Susan M. C/O MARIMED INC. 10 OCEANA WAY NORWOOD,, MA 02062 |
|
| Chief Financial Officer |
|
Signatures
|
/s/ Susan M. Villare | | 5/18/2022 |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
MariMed (QX) (USOTC:MRMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
MariMed (QX) (USOTC:MRMD)
Historical Stock Chart
From Apr 2023 to Apr 2024